Our Life Sciences UPC Litigation team is proud to announce that, together with teams at patent attorney firm Boult and Dutch lawyers at De Brauw Blackstone Westbroek, they have secured a victory for US company Molecular Instruments in a patent litigation case before the Unified Patent Court (UPC), Local Division of the Hague.

The combined team led Molecular Instruments to success in the patent infringement claim brought by Advanced Cell Diagnostics. The UPC has held that Molecular Instruments' proprietary HCR™ RNA-ISH bioimaging technology does not infringe the patents of Advanced Cell Diagnostics.

The win is two in a row for Molecular Instruments and our Life Sciences team, having already achieved a successful outcome in 2024 on the same patents in the High Court of England & Wales which held them not to be valid.

Our core team comprised Huw Evans, Marianne Schaffner, Alex Driver, Felicity Wade-Palmer, Ollie Carpenter and Mathilde Grammont, with support from a number of others across the wider sector group.

Gowling WLG's Life Sciences team has the technical understanding required to advise on the unique challenges companies face throughout their life cycles. They draw on first-hand industry experience and extensive legal expertise to guide and support business, intellectual property, human resource and regulatory teams in the life sciences sector. Their extensive experience, innovative work and first-hand insight into the sector sees the team consistently top ranked in Chambers UK, where clients recognise its "deep expertise" and "solution-orientated and proactive approach" on a wide range of matters.